METASTATIC CANCER OF THE PROSTATE MANAGED WITH BUSERELIN VERSUS BUSERELIN PLUS CYPROTERONE-ACETATE

被引：43

作者：

SCHROEDER, FH

LOCK, TMTW

CHADHA, DR

DEBRUYNE, FMJ

KARTHAUS, HFM

DEJONG, FH

KLIJN, JGM

MATROOS, AW

DEVOOGT, HJ

机构：

[1] ERASMUS UNIV, DEPT BIOCHEM 2, 3000 DR ROTTERDAM, NETHERLANDS

[2] ERASMUS UNIV, DEPT INTERNAL MED 3, 3000 DR ROTTERDAM, NETHERLANDS

[3] DANIEL DENHOED CANC CTR, ROTTERDAM, NETHERLANDS

[4] HOECHST HOLLAND NV, CLIN RES DEPT, AMSTERDAM, NETHERLANDS

[5] CATHOLIC UNIV NIJMEGEN, DEPT UROL, NIJMEGEN, NETHERLANDS

[6] FREE UNIV AMSTERDAM, DEPT UROL, 1007 MC AMSTERDAM, NETHERLANDS

来源：

JOURNAL OF UROLOGY | 1987年 / 137卷 / 05期

关键词：

D O I：

10.1016/S0022-5347(17)44293-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：912 / 918

页数：7

共 25 条

[1]

AHMED SR, 1983, LANCET, V2, P415

[2] LONG-TERM SUPPRESSION OF TESTOSTERONE PRODUCTION BY AN LH-RH AGONIST (BUSERELIN, HOE-766) IN PATIENTS WITH ADVANCED-CARCINOMA OF THE PROSTATE - A NEW THERAPEUTIC APPROACH [J].

BORGMANN, V ;

NAGEL, R ;

SCHMIDTGOLLWITZER, M ;

HARDT, W .

AKTUELLE UROLOGIE, 1982, 13 (04) :200-203

[3]

DEBRUYNE FMJ, 1985, EORTC GENITOURINAR A, V2, P251

[4] RAPID AND RELIABLE SEPARATION OF 5-ALPHA-DIHYDROTESTOSTERONE FROM TESTOSTERONE ON SILICA-GEL MICROCOLUMNS [J].

HAMALAINEN, EK ;

FOTSIS, T ;

ADLERCREUTZ, H .

CLINICA CHIMICA ACTA, 1984, 139 (02) :173-177

[5] A VERSATILE METHOD FOR THE DETERMINATION OF SERUM CORTISOL BINDING GLOBULIN AND SEX-HORMONE BINDING GLOBULIN BINDING-CAPACITIES [J].

HAMMOND, GL ;

LAHTEENMAKI, PLA .

CLINICA CHIMICA ACTA, 1983, 132 (01) :101-110

[6]

JACOBI GH, 1982, EUR UROL, V8, P129

[7]

KLIGN JGM, 1985, LANCET, V2, P493

[8] IMPORTANCE OF PITUITARY-TUMOR SIZE IN PATIENTS WITH HYPER-PROLACTINEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOR [J].

KLIJN, JGM ;

LAMBERTS, SWJ ;

DEJONG, FH ;

DOCTER, R ;

VANDONGEN, KJ ;

BIRKENHAGER, JC .

CLINICAL ENDOCRINOLOGY, 1980, 12 (04) :341-355

[9]

Labrie F, 1985, Important Adv Oncol, P193

[10] SIMULTANEOUS ADMINISTRATION OF PURE ANTIANDROGENS, A COMBINATION NECESSARY FOR THE USE OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS IN THE TREATMENT OF PROSTATE-CANCER [J].

LABRIE, F ;

DUPONT, A ;

BELANGER, A ;

EMOND, J ;

MONFETTE, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (12) :3861-3863

← 1 2 3 →